Announcement – Daren Oddenino Joins HCA

Announcement - daren oddenino joins hca

Hexagon Capital Alliance Expands Its Healthcare Investment Banking Practice

Hexagon Capital Alliance is pleased to announce it has recently hired Daren Oddenino as a Director for the firm’s rapidly growing healthcare practice.  Daren is an accomplished healthcare investment banker who has over 17 years of capital markets, advisory, and banking experience across the spectrum of M&A, recapitalizations, and debt and equity capital raises for both public and private entities.  His focus within healthcare includes Multi-Site, Physician Practices, Behavioral Healthcare, Home Health & Hospice, Healthcare Staffing, and Healthcare Technology.

“We are thrilled to have Daren join our growing healthcare practice,” said Paul Kacik, Managing Director and Head of Healthcare Investment Banking at Hexagon Capital Alliance.  “He brings to the firm a wealth of experience serving as a trusted advisor to founder and clinician-owned healthcare companies.  This comes at a time when M&A transaction activity in the healthcare sector remains extremely strong.  We look forward to working with Daren as an integral part of our team.”

Daren Oddenino commented, “I am honored to join the Hexagon Capital Alliance team.  The firm has a long-standing reputation as a leading investment banking advisor with extensive relationships in the middle-market.  I look forward to working alongside the team as we accelerate the growth of the healthcare practice.”

Rich Anderson, Managing Partner, added, “The addition of Daren brings 50 years of collective sector experience within Hexagon’s healthcare team.  Paul Kacik, Brad Erhart, and Daren Oddenino, Hexagon’s senior healthcare bankers, are well-suited to advise founders on how to prepare for and execute a transaction that meets the needs of stakeholders and the business.”

Prior to joining Hexagon Capital Alliance, Daren was a senior banker at multiple firms with leading healthcare practices, including J.P. Morgan, Cain Brothers/KeyBanc Capital Markets, and Ziegler.  He has a bachelor’s degree in economics from the University of Utah. 

To reach the Healthcare Services team, please contact:

Paul Kacik, Managing Director: [email protected]

Brad Erhart, Director: [email protected]

Daren Oddenino, Director: [email protected]

Looking Ahead – Key M&A Themes in 2023

Looking Ahead - Key M&A Themes in 2023

Strategic acquirers and financial sponsors alike were busy putting capital to work which culminated in a dizzying 24 months of record-setting M&A activity.  However, a valuation correction, which arguably began in the second half of 2022, is expected to carry over in 2023 as monetary tightening and interest rate hikes continue.  As the fight for price stability wages forward, many industry experts predict 2023 transaction activity will be ‘muted’ relative to the past two years, but not ‘decimated’ as witnessed during the Great Recession.

Private Equity acquirers are calibrating market valuations and investment theses under a fresh economic cycle.  Rising borrowing costs, pressure on key equity return metrics, and macro-economic uncertainty is creating a melting pot of ‘noise’ when it comes to business valuations.  Smaller target acquisitions will become more prominent – “add-ons” are generally quicker to digest and integrate and can sometimes be acquired at more favorable valuations while also meeting growth criterion.  Private debt funds, or non-bank lenders, will be a primary source of financing as the asset class continues its meteoric rise and abundant deployable capital (‘dry powder’).  Heightened scrutiny in due diligence – all acquirer-affiliated constituents (investors, quality-of-earnings, insurance, operations, environmental, human resources, legal, etc.) are on high alert taking special care when identifying and allocating the risks between counterparties.

Strategic acquirers to continue dominating the proportion of middle-market M&A activity in 2023.  Corporate acquirers have significant deployable cash on-hand and existing credit facilities after more than a decade of shoring-up balance sheets.  The last two years of cash preservation and debt repayment tactics have further expanded capital allocations to M&A strategies.                Strategic fit, growth characteristics, and cash flow resilience will determine a premium vs. discounted valuation for middle-market businesses.

We anticipate strategic buyers to prevail in most large middle-market company transaction processes, while financial sponsors focus on smaller middle-market businesses that complement their existing portfolio investments.   Premium valuations will be awarded to those companies that are outperforming their peer groups.

Hexagon Capital Alliance has a 23-year history of assisting business owners in planning and executing on their personal and corporate liquidity objectives.  All deals start with a conversation.  We are here to listen then present alternatives to help business owners make informed decisions.